Article
New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.
Current neurology and neuroscience reports - 1 May 2016
Lutz Michael W, Crenshaw Donna, Welsh-Bohmer Kathleen A, Burns Daniel K, Roses Allen D
Abstract excerpt
Clinical trials for Alzheimer's disease are now focusing on the earliest stages of the disease with the goal of delaying dementia onset. There is great utility in using genetic variants to identify individuals at high age-dependent risk when the goal is to begin treatment before the development of any cognitive symptoms. Genetic variants identified through large-scale genome-wide association studies have not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
